Literature DB >> 16941276

IL-18: relationship with anthropometry, body composition parameters, leptin and arterial hypertension.

N Vilarrasa1, J Vendrell, J Maravall, M Broch, A Estepa, A Megia, J Soler, I Simón, C Richart, J M Gómez.   

Abstract

OBJECTIVE: Interleukin-18 (IL-18) is a potent pro-inflammatory cytokine with potential atherogenic properties whose role in human obesity has been recently suggested. The aim of our study was to analyze the physiologic distribution of IL-18 among sexes and all decades of the adult life in a healthy population randomly selected and to study its relationship with anthropometric, body composition measurements and leptin concentrations. We also studied the relationship of IL-18 with smoking and arterial hypertension, known risk factors implicated in atherogenesis.
MATERIALS AND METHODS: One hundred and thirty four men and 127 healthy women were included in the study. Plasma concentrations of IL-18 and leptin were determined in all subjects. Body composition was evaluated by bioelectrical impedanciometry.
RESULTS: IL-18 was distributed similarly in men and women and throughout decades. No significant differences were found in IL-18 between obese and normal-weight men and women according to their body mass index and body fat content. Higher IL-18 concentrations were found in subjects with arterial hypertension. In the bivariate correlation analysis only waist to hip ratio correlated weakly with IL-18 in the whole population (r=0.12, p=0.04). In the multiple regression analysis the relationship between IL-18 and waist to hip ratio lost significance after adjusting for age, sex and body mass index. However, IL-18 remained associated with arterial hypertension (adjusted r2=0.25, p=0.023).
CONCLUSIONS: The lack of correlation between IL-18 with anthropometric, body composition variables and leptin in our healthy population argues against a role of this cytokine in obesity. Moreover, our findings suggest the implication of this interleukin in the atherogenic process induced by arterial hypertension.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16941276     DOI: 10.1055/s-2006-949122

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  5 in total

1.  Circulating IL-18 and the risk of type 2 diabetes in women.

Authors:  M F Hivert; Q Sun; P Shrader; C S Mantzoros; J B Meigs; F B Hu
Journal:  Diabetologia       Date:  2009-08-08       Impact factor: 10.122

2.  Inflammation and Change in Body Weight With Antiretroviral Therapy Initiation in a Multinational Cohort of HIV-Infected Adults.

Authors:  Vidya Mave; Kristine M Erlandson; Nikhil Gupte; Ashwin Balagopal; David M Asmuth; Thomas B Campbell; Laura Smeaton; Nagalingeswaran Kumarasamy; James Hakim; Breno Santos; Cynthia Riviere; Mina C Hosseinipour; Patcharaphan Sugandhavesa; Rosa Infante; Sandy Pillay; Sandra W Cardoso; Srikanth Tripathy; Noluthando Mwelase; Sima Berendes; Bruno B Andrade; David L Thomas; Robert C Bollinger; Amita Gupta
Journal:  J Infect Dis       Date:  2016-03-08       Impact factor: 5.226

Review 3.  The role of interleukin 18 in the pathogenesis of hypertension-induced vascular disease.

Authors:  Simon W Rabkin
Journal:  Nat Clin Pract Cardiovasc Med       Date:  2009-03

4.  Association Between Interleukin-18 Level and Left Ventricular Mass Index in Hypertensive Patients.

Authors:  Süleyman ÖZzbïçer; Zekiye Melek Uluçam
Journal:  Korean Circ J       Date:  2017-03-13       Impact factor: 3.243

5.  Angiotensinogen and interleukin 18 in serum and urine of children with kidney cysts.

Authors:  Krzysztof Plesiński; Piotr Adamczyk; Elżbieta Świętochowska; Aurelia Morawiec-Knysak; Aleksandra Gliwińska; Omar Bjanid; Maria Szczepańska
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2019 Jul-Sep       Impact factor: 1.636

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.